Griffin Stephen D. 4
4 · Anika Therapeutics, Inc. · Filed Jun 5, 2025
Insider Transaction Report
Form 4
Griffin Stephen D.
DirectorPresident and CEO
Transactions
- Exercise/Conversion
Common Stock
2025-06-03+12,840→ 13,640 total - Tax Payment
Common Stock
2025-06-03$11.59/sh−3,769$43,683→ 9,871 total - Exercise/Conversion
Restricted Stock Unit
2025-06-03+12,840→ 25,680 totalExercise: $0.00→ Common Stock (12,840 underlying)
Footnotes (5)
- [F1]Reflects the first vesting installment of RSUs granted on June 3, 2024.
- [F2]Includes 800 shares acquired on May 14, 2025 under the Anika Therapeutics, Inc. Employee Stock Purchase Plan.
- [F3]Reflects an aggregate of 3,769 shares of common stock retained by the Issuer to satisfy tax withholding obligations with respect to RSUs that vested on June 3, 2025.
- [F4]Reflects the closing price of ANIK common stock on June 3, 2025, the trading date on which the vesting of RSUs gave rise to tax withholding obligations.
- [F5]Each RSU represents the contingent right to receive one share of the Company's common stock. The RSUs vest in three equal annual installments beginning June 3, 2025.